Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs

Jenna G. Wooten Gastrointestinal Biology Research Laboratory, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.

Search for other papers by Jenna G. Wooten in
Current site
Google Scholar
PubMed
Close
 BS
,
Anthony T. Blikslager Gastrointestinal Biology Research Laboratory, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.

Search for other papers by Anthony T. Blikslager in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Kathleen A. Ryan Gastrointestinal Biology Research Laboratory, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.

Search for other papers by Kathleen A. Ryan in
Current site
Google Scholar
PubMed
Close
 BS
,
Steve L. Marks Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.

Search for other papers by Steve L. Marks in
Current site
Google Scholar
PubMed
Close
 BVSc, MS
,
J. Mac Law Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.

Search for other papers by J. Mac Law in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
B. Duncan X. Lascelles Comparative Pain Research Laboratory, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606.

Search for other papers by B. Duncan X. Lascelles in
Current site
Google Scholar
PubMed
Close
 BVSc, PhD
Restricted access
Purchase Article

Abstract

Objective—To assess cyclooxygenase (COX) expression and prostanoid concentrations in pyloric and duodenal mucosae of dogs after administration of nonsteroidal anti-inflammatory drugs (NSAIDs).

Animals—8 healthy dogs.

Procedures—Each dog received carprofen (4.4 mg/kg, q 24 h), deracoxib (2 mg/kg, q 24 h), aspirin (10 mg/kg, q 12 h), and placebo (1 dog treat, q 24 h) orally for 3 days (4-week interval between treatments). Before study commencement (baseline) and on day 3 of each treatment, pyloric and duodenal mucosal appearance was assessed endoscopically and biopsy specimens were obtained for histologic examination. Cyclooxygenase-1 and COX-2 protein expressions were assessed via western blotting, and prostanoid concentrations were measured via ELISAs. An ANOVA was used to analyze data.

Results—Treatments had no effect on mucosal appearance and ulceration was not evident histologically. In pyloric and duodenal mucosae, COX-1 expression was unaffected by treatments. Cyclooxygenase-2 expression remained unchanged in pyloric mucosa; in duodenal mucosa, aspirin significantly increased COX-2 expression, compared with effects of deracoxib and carprofen. At baseline, total prostaglandin and thromboxane B2 concentrations in pyloric mucosa were significantly greater than those in duodenal mucosa. Aspirin significantly decreased both prostanoid concentrations in both mucosal tissues, compared with other treatments. In pyloric mucosa, carprofen administration significantly decreased total prostaglandin and thromboxane B2 concentrations, compared with deracoxib administration.

Conclusions and Clinical Relevance—In dogs, prostanoid synthesis was greater in pyloric mucosa than it was in duodenal mucosa. Nonselective NSAIDs significantly decreased prostanoid concentrations in these mucosae, compared with the effects of a selective COX-2 NSAID.

All Time Past Year Past 30 Days
Abstract Views 119 0 0
Full Text Views 3010 2395 137
PDF Downloads 317 84 5
Advertisement